Regulation of the wild-type and Y1235D mutant Met kinase activation.

Regulation of the wild-type and Y1235D mutant Met kinase activation.

Met receptor tyrosine kinase plays a crucial role in the regulation of a large number of cellular processes and, when deregulated by overexpression or mutations, leads to tumor growth and invasion. The Y1235D mutation identified in metastases was shown to induce constitutive activation and a motile-...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Cristiani, C, Rusconi, L, Perego, R, Schiering, N, Kalisz, H, Knapp, S, Isacchi, A
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2005

Gelijkaardige items

Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a.
door: Schiering, N, et al.
Gepubliceerd in: (2003)

Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancer
door: Ling Lim, et al.
Gepubliceerd in: (2019-01-01)

Rescue of NBD2 mutants N1303K and S1235R of CFTR by small-molecule correctors and transcomplementation.
door: Daniele Rapino, et al.
Gepubliceerd in: (2015-01-01)

Kurultai of 1235: Question of Expansion of the Ulus of Jochi »
door: I.М. Mirgaleev
Gepubliceerd in: (2014-09-01)

Activation of Zap-70 tyrosine kinase due to a structural rearrangement induced by tyrosine phosphorylation and/or ITAM binding.
door: Visco, C, et al.
Gepubliceerd in: (2000)

P1235: INVESTIGATION OF THE CO-MUTATIONAL LANDSCAPE OF ALK-POSITIVE ALCL
door: Matteo Villa, et al.
Gepubliceerd in: (2023-08-01)

Early Hungarian Information about the Mongol Western Campaign (1235–1242) »
door: Roman Hautala
Gepubliceerd in: (2015-09-01)

1,2,3,5-Tetrahydronaphtho[2,1-c]oxepine
door: Alan J. Lough, et al.
Gepubliceerd in: (2020-03-01)

Preparation of 4-benzylsulfanyl[1,2,3,5]dithiadiazol-1-ylium chlorides: potential precursors to meso-ionic 1,2,3,5-dithiadiazolium-4-thiolate
door: Thomas Gelbrich, et al.
Gepubliceerd in: (2002-10-01)

Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia
door: Burcu Aslan, et al.
Gepubliceerd in: (2022-05-01)

1235 Safety of Immune checkpoint inhibitors in elderly patients over 75 years
door: Muhammad Awidi, et al.
Gepubliceerd in: (2023-11-01)

Tau decay into $$\nu _\tau $$ ντ and $$a_1(1260)$$ a1(1260) , $$b_1(1235)$$ b1(1235) , and two $$K_1(1270)$$ K1(1270)
door: L. R. Dai, et al.
Gepubliceerd in: (2020-07-01)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
door: Zhe Zhang, et al.
Gepubliceerd in: (2019-11-01)

Proteome Regulation Patterns Determine Escherichia coli Wild-Type and Mutant Phenotypes
door: Tobias B. Alter, et al.
Gepubliceerd in: (2021-04-01)

Differential responses of MET activations to MET kinase inhibitor and neutralizing antibody
door: Jianqun Kou, et al.
Gepubliceerd in: (2018-09-01)

1,2,3,5-Tetramethyl-1H-pyrazol-2-ium triiodide
door: Stefan Oberparleiter, et al.
Gepubliceerd in: (2016-08-01)

Observing student´s syntactic errors and the perceptions towards writing in the composition course LM-1235
door: César Alberto Navas Brenes
Gepubliceerd in: (2017-04-01)

History from Comic Hypotheses: Stratocles, Lachares, and <i>P.Oxy. 1235</i>
door: Lara O'Sullivan
Gepubliceerd in: (2010-11-01)

In silico analysis of wild-type and mutant KRAS
door: Frengki Frengki, et al.
Gepubliceerd in: (2019-05-01)

Raoul de Houdenc et les routes noveles de la fiction 1200-1235
door: Fernando Carmona Fernández
Gepubliceerd in: (2019-12-01)

Protein tyrosine phosphatase receptor type E (PTPRE) regulates the activation of wild-type KIT and KIT mutants differently
door: Shaoting Zhang, et al.
Gepubliceerd in: (2021-07-01)

Aurora kinase-C-T191D is constitutively active mutant
door: Khan Jabbar, et al.
Gepubliceerd in: (2012-03-01)

Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant
door: Wenshu Li, et al.
Gepubliceerd in: (2024-07-01)

Redox Sensitive Cysteine Residues as Crucial Regulators of Wild-Type and Mutant p53 Isoforms
door: Elena Butturini, et al.
Gepubliceerd in: (2021-11-01)

Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
door: Figeys Daniel, et al.
Gepubliceerd in: (2008-09-01)

Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma
door: Chao Sun, et al.
Gepubliceerd in: (2020-04-01)

Vecabrutinib inhibits B-cell receptor signal transduction in chronic lymphocytic leukemia cell types with wild-type or mutant Bruton tyrosine kinase
door: Burcu Aslan, et al.
Gepubliceerd in: (2021-09-01)

Glucose Starvation Alters Heat Shock Response, Leading to Death of Wild Type Cells and Survival of MAP Kinase Signaling Mutant.
door: Nora Plesofsky, et al.
Gepubliceerd in: (2016-01-01)

Transformation of HepG2 nascent lipoproteins by LCAT: modulation by HepG2 d > 1.235 g/ml fraction.
door: MR McCall, et al.
Gepubliceerd in: (1993-01-01)

In silico analysis of the wild-type and mutant-type of BRCA2 gene
door: Jingjing Li, et al.
Gepubliceerd in: (2024-05-01)

The 4-(3-chloro-4-methylphenyl)-1,2,3,5-dithiadiazol-3-yl radical
door: Jacqueline M. Cole, et al.
Gepubliceerd in: (2011-09-01)

Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
door: Dai Yao, et al.
Gepubliceerd in: (2012-05-01)

Metabolomics of 293T IDH1 mutant and wild-type cells
door: Walsby-Tickle, J
Gepubliceerd in: (2020)

Normalization of NPM1 mutant transcript to the wild‐type transcript
door: Lawrence J. Jennings
Gepubliceerd in: (2022-11-01)

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability
door: YiQing Lü, et al.
Gepubliceerd in: (2024-04-01)

Retraction: Aurora kinase-C-T191D is constitutively active mutant
door: Khan Jabbar, et al.
Gepubliceerd in: (2012-06-01)

Antitumor imidazotetrazines. 38. New 8-substituted derivatives of the imidazo[5,1-d]-1,2,3,5-tetrazines temozolomide and mitozolomide
door: David A. F. Langnel, et al.
Gepubliceerd in: (2000-08-01)

N-Benzyl-6-deoxy-3,6-iminomethylene-1,2,3,5-O-tetraacetyl-&#945;-d-1(S)-epiallofuranose
door: Qiurong Zhang, et al.
Gepubliceerd in: (2011-06-01)

In vitro effectiveness of CB469, a MET tyrosine kinase inhibitor in MET-activated cancer cells
door: Ji Yeon Song, et al.
Gepubliceerd in: (2024-11-01)

Molecular Dynamics and Optimization Studies of Horse Prion Protein Wild Type and Its S167D Mutant
door: Jiapu Zhang
Gepubliceerd in: (2024-08-01)